Clinical Trial Update: CHOOSE : Telithromycin, Acute Bacterial Sinusitis [Phase 4]

View source ↗

Summary

The Phase 4 CHOOSE trial evaluating telithromycin for acute bacterial sinusitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Sinusitis

Drugs mentioned

• Ketek (telithromycin)

Snippet

Sponsor: Sanofi | Conditions: Sinusitis | Phase 4 | Status: COMPLETED